All Science & Innovation Theaters take place on Thursday, Oct. 22 between 4:00-5:10pm. Instructions will be included on the Nexus 2020 Virtual platform.
Science & Innovation Theaters provide a structured focus for participants to gain information on specific products, therapeutic areas and/or disease states in presentations provided by company designated presenters.*
Materials presented in theaters may be promotional and concentrate on a specific product, service, or therapeutic area. Therefore, these presentations are considered promotional and do not offer continuing education credit.
Thursday, Oct. 22 | 4-4:30pm
Acute Exacerbations: Predictors of Poor Outcomes in COPD
Sponsored by AstraZeneca
This program will examine the risk factors associated with COPD exacerbations and the potential impacts of acute exacerbations on patient health, quality of life, and mortality. An understanding of COPD exacerbations and the range of consequences highlights opportunities to optimize COPD management earlier in the course of disease.
Igor Barjaktarevic, MD, PhD
Medical Director, COPD Program at UCLA
Director of Critical Care Ultrasound
UCLA Division of Pulmonary and Critical Care
David Geffen School of Medicine at University of California Los Angeles
Thursday, Oct. 22 | 4:45-5:15pm
Theater title, description and speaker(s) coming soon.
* Science & Innovation Theaters may include preapproved information exchange content. Subject to federal laws and regulations, attendance at PIE sessions is restricted to payors, formulary committee, or other similar entity representatives with knowledge and expertise in the area of health care economic analysis, carrying out responsibilities for the selection of drugs for coverage or reimbursement. For more information, visit our website.